药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Levorphanol
Trastuzumab emtansine
The serum concentration of Trastuzumab emtansine can be increased when it is combined with Lapatinib.
Levorphanol
Cobimetinib
The serum concentration of Cobimetinib can be increased when it is combined with Lapatinib.
Levorphanol
Temsirolimus
The serum concentration of Temsirolimus can be increased when it is combined with Lapatinib.
Levorphanol
Digitoxin
The serum concentration of Digitoxin can be increased when it is combined with Lapatinib.
Levorphanol
Romidepsin
The serum concentration of Romidepsin can be increased when it is combined with Lapatinib.
Levorphanol
Ebastine
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Ebastine.
Levorphanol
Rilpivirine
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Rilpivirine.
Levorphanol
Lurasidone
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Lurasidone.
Levorphanol
Celiprolol
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Celiprolol.
Levorphanol
Lidoflazine
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Lidoflazine.
Levorphanol
Bencyclane
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Bencyclane.
Levorphanol
Gallopamil
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Gallopamil.
Levorphanol
Tetrahydropalmatine
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Tetrahydropalmatine.
Levorphanol
Delafloxacin
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Delafloxacin.
Levorphanol
Rupatadine
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Rupatadine.
Levorphanol
Niguldipine
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Niguldipine.
Levorphanol
Lacidipine
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Lacidipine.
Levorphanol
Efonidipine
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Efonidipine.
Levorphanol
Aranidipine
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Aranidipine.
Levorphanol
Pinaverium
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Pinaverium.